SAMANTHA STEIN: Open Payments
NPI 1275124547 · SAN FRANCISCO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,243 in 173 payments from 19 companies in 2025. Trend: 2023 $835 · 2024 $3,050 · 2025 $4,243
Food & beverage: $3,956Education: $287
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 23 | $562 |
| Incyte Corporation | 23 | $417 |
| Regeneron Healthcare Solutions, Inc. | 10 | $380 |
| ABBVIE INC. | 10 | $362 |
| UCB, Inc. | 12 | $347 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 19 | $299 |
| GENZYME CORPORATION | 10 | $295 |
| Organon LLC | 3 | $263 |
| Galderma Laboratories, L.P. | 9 | $205 |
| Janssen Biotech, Inc. | 5 | $197 |
Products named: DUPIXENT, Zoryve, OPZELURA, Bimzelx, SKYRIZI, VTAMA, Winlevi, NEMLUVIO.
Industry payments across CA — which companies pay providers there.
